Cover Page

Cite item


Aim: To study an association between acrochordon and human papilloma virus (HPV) using quantitative analysis of viral desoxyribonucleic acid (DNA); to detect different phenotypes of beta-HPV. Materials and methods: We examined 52  patients (22 immuno-suppressed patients and 30 immunocompetent subjects) in the Dermatovenereology and Dermato-Oncology Department and Chronic Dialysis and Kidney Transplantation Department of the Moscow Regional Research and Clinical Institute (MONIKI). Control group included 49 healthy donors. Burr biopsy samples (micro-samples) of acrochordon and intact skin (apper arm) were collected in sterile conditions. After sample procession and DNA isolation using DNK-sorb-C kit (Central Research Institute for Epidemiology – CRIE), polymerase chain reaction for HPV was performed with real-time fluorescent hybridization detection. For DNA amplification and detection we used RotorGene 3000 analyzer (Corbett Research, Australia). In the beta-HPV assay, recombinant plasmids were used as positive controls and control human beta-globin gene fragments (CRIE). 4 oligo-nucleotide systems (group-specific primers and probes) were used for the detection of beta-HPV DNA. Results: Preliminary data indicated that acrochordons of open and covered skin regions were common in renal transplant recipients. Beta-HPV DNA was more frequent in acrochordons and intact skin (64% and 54%) of renal transplant recipients compared to healthy donors (47%). 57% of renal transplant recipients demonstrated mixed infection in acrochordons. Conclusion: HPV DNA was frequently detected in acrochordons and intact skin of renal transplant recipients. In immunocompetent patients prevalence of HPV DNA in acrochordons was significantly higher compared to intact skin.

About the authors

V. A. Molochkov

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

MD, PhD, Professor, Head of the Dermatovenereology and Dermato-Oncology Departmen Russian Federation

L. V. Korneva

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Author for correspondence.
MD, PhD, Assistant Professor, Dermatovenereology and Dermato-Oncology Department Russian Federation

E. S. Snarskaya

I.M. Sechenov First Moscow State Medical University; 8/2 Trubetskaya ul., Moscow, 119991, Russian Federation

MD, PhD, Professor, Department of Skin and Venereal Diseases, Institute for Professional Education Russian Federation

E. O. Shcherbakova

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

MD, PhD, Senior Research Associate, Chronic Dialysis and Kidney Transplantation Department Russian Federation

A. A. Polyanskaya

Medical Aesthetics Clinic “Premium Aesthetics”; 3–6 Kazarmennyy pereulok, Moscow, 109028, Russian Federation

Dermatovenereologist, Cosmetologis Russian Federation

E. K. Nodel’man

Central Research Institute for Epidemiology; 3а Novogireevskaya ul., Moscow, 111123, Russian Federation

PhD, Junior Research Associate, Molecular Diagnosis and Epidemiology Department Russian Federation


  1. World Health Organization International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. V. 90. Human Papillomaviruses. Lyon; 2007. 674 p.
  2. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol. 2000;61(3):289–97.
  3. de Jong-Tieben LM, Berkhout RJ, ter Schegget J, Vermeer BJ, de Fijter JW, Bruijn JA, Westendorp RG, Bouwes Bavinck JN. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation. 2000;69(1):44–9.
  4. Кладова АЮ, Куевда ДА, Молочков ВА, Шипулина ОЮ, Киселев ВИ, Хлебникова АН, Козлова ЕС. Встречаемость кожных типов вируса папилломы человека в патологиях кожи. Альманах клинической медицины. 2006;9:44–50. (Kladova AYu, Kuevda DA, Molochkov VA, Shipulina OYu, Kiselev VI, Khlebnikova AN, Kozlova ES. [Prevalence of skin types of human papilloma virus in skin lesions]. Al’manakh klinicheskoy meditsiny. 2006;9:44–50. Russian).
  5. Галил-Оглы ГА, Молочков ВА, Сергеев ЮВ. Дерматоонкология. М.: Медицина; 2005. 865 с. (Galil-Ogly GA, Molochkov VA, Sergeev YuV. Dermato-Oncology. Moscow: Meditsina; 2005. 865 р. Russian).
  6. Chen QP, Aw DC. Epidemiology of skin diseases in renal transplant recipients in a tertiary hospital. Ann Acad Med Singapore. 2010;39(12):904–5.
  7. Dianzani C, Calvieri S, Pierangeli A, Imperi M, Bucci M, Degener AM. The detection of human papillomavirus DNA in skin tags. Br J Dermatol. 1998;138(4):649–51.
  8. Sallam MA, Kamel MM, Missiry AGE, Helal MF. Detection of some types of human papillomaviruses in skin tags. Sci J Al-Azhar Med. 2003;24:311–7.
  9. Pezeshkpoor F, Jafarian AH, Ghazvini K, Yazdanpanah MJ, Sadeghian A, Esmaili H, Karrabi M, Rohani F, Joushan B. An association of human papillomaviruses low risk and high risk subtypes with skin tag. Iran J Basic Med Sci. 2012;15(3):840–4.
  10. Куевда ДА, Кладова АЮ, Шипулина ОЮ, Молочков ВА. Разработка методики количественного определения папилломавирусов рода бета. В: Материалы VI научно-практической конференции «Социально значимые заболевания в дерматовенерологии. Диагностика, терапия, профилактика». М.; 2006. с. 97–8. (Kuevda DA, Kladova AYu, Shipulina OYu, Mo-lochkov VA. Development of beta-pa pilloma virus assay. In: Proceedings of the VI Research-to-Practice Conference “Socially Significant Diseases in Dermatovenereology. Diagnosis, Therapy, Prevention”. Moscow; 2006. p. 97–8. Russian).

Copyright (c) 2014 Molochkov V.A., Korneva L.V., Snarskaya E.S., Shcherbakova E.O., Polyanskaya A.A., Nodel’man E.K.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies